Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Oncology
|
August 10, 2005
A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer
Chong-Xian Pan, Patrick Loehrer, David Seitz, et al.
Ecancermedicalscience
|
October 18, 2024
'Addressing HPV vaccine hesitancy: unveiling concerns and building trust' perspectives of adolescent girls and parents in Kisumu County, Kenya
Edwin Onyango Ochomo, Philiph Tonui, Kapten Muthoka, et al.
American Journal of Clinical Oncology
|
April 9, 2008
Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial
Tomislav Dragovich, Howard Burris, Patrick Loehrer, et al.
JCO Global Oncology
|
March 19, 2021
Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya
Mercy A Oduor, Teresa C Lotodo, Terry A Vik, et al.
Ecancermedicalscience
|
March 4, 2026
Text messaging to improve uptake of human papillomavirus vaccination: a study among adolescent girls living with HIV in Kisumu county
Ochomo Edwin Onyango, Philiph Tonui, Peter Itsura, et al.
Ecancermedicalscience
|
April 28, 2023
Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence <i>in situ</i> hybridisation testing for <i>MYC</i> and the <i>MYC/IGH</i> translocation
Gail H Vance, Teresa Lotodo, Nicholas Kigen, et al.
Research Square
|
February 7, 2023
Association of Plasma Aflatoxin With Persistent Detection of Oncogenic Human Papillomaviruses in Cervical Samples From Kenyan Women Enrolled in a Longitudinal Study
Yan Tong, Philip Tonui, Omenge Orang'o, et al.
BMC Infectious Diseases
|
June 6, 2023
Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study
Yan Tong, Philip Tonui, Omenge Orang'o, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 2, 2023
Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198)
Walid L Shaib, Rupji Manali, Yuan Liu, et al.
Open Forum Infectious Diseases
|
August 9, 2019
Detection and Concentration of Plasma Aflatoxin is Associated with Detection of Oncogenic Human Papillomavirus in Kenyan Women
Jianjun Zhang, Omenge Orang'o, Philip Tonui, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Oncology
|
August 10, 2005
A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer
Chong-Xian Pan, Patrick Loehrer, David Seitz, et al.
Ecancermedicalscience
|
October 18, 2024
'Addressing HPV vaccine hesitancy: unveiling concerns and building trust' perspectives of adolescent girls and parents in Kisumu County, Kenya
Edwin Onyango Ochomo, Philiph Tonui, Kapten Muthoka, et al.
American Journal of Clinical Oncology
|
April 9, 2008
Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial
Tomislav Dragovich, Howard Burris, Patrick Loehrer, et al.
JCO Global Oncology
|
March 19, 2021
Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya
Mercy A Oduor, Teresa C Lotodo, Terry A Vik, et al.
Ecancermedicalscience
|
March 4, 2026
Text messaging to improve uptake of human papillomavirus vaccination: a study among adolescent girls living with HIV in Kisumu county
Ochomo Edwin Onyango, Philiph Tonui, Peter Itsura, et al.
Ecancermedicalscience
|
April 28, 2023
Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence <i>in situ</i> hybridisation testing for <i>MYC</i> and the <i>MYC/IGH</i> translocation
Gail H Vance, Teresa Lotodo, Nicholas Kigen, et al.
Research Square
|
February 7, 2023
Association of Plasma Aflatoxin With Persistent Detection of Oncogenic Human Papillomaviruses in Cervical Samples From Kenyan Women Enrolled in a Longitudinal Study
Yan Tong, Philip Tonui, Omenge Orang'o, et al.
BMC Infectious Diseases
|
June 6, 2023
Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study
Yan Tong, Philip Tonui, Omenge Orang'o, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 2, 2023
Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198)
Walid L Shaib, Rupji Manali, Yuan Liu, et al.
Open Forum Infectious Diseases
|
August 9, 2019
Detection and Concentration of Plasma Aflatoxin is Associated with Detection of Oncogenic Human Papillomavirus in Kenyan Women
Jianjun Zhang, Omenge Orang'o, Philip Tonui, et al.
Page
of 3